The Patent Finder

Tecnogen S.p.A.

Also on record
Records under this name other than patents Tecnogen S.p.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Tecnogen S.p.A.

PatentTitleStatus Expires Confidence
US 7,989,171Anti-human tenascin monoclonal antibody
Formerly held
Lapsed on the fee record
Ended Aug 2, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 2, 2023From the USPTO record
US 8,883,446Human long pentraxin 3 expression system and uses thereof
Formerly held
Lapsed on the fee record
Ended Nov 11, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2022From the USPTO record
US 8,268,304Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
Formerly held
Lapsed on the fee record
Ended Sep 18, 2020 · From the USPTO record
Lapsed on the fee recordEnded Sep 18, 2020From the USPTO record
US 8,076,300FGF2-binding peptides and uses thereof
Formerly held
Lapsed on the fee record
Ended Dec 13, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2019From the USPTO record
US 7,910,092Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
Formerly held
Lapsed on the fee record
Ended Mar 22, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 22, 2019From the USPTO record
US 8,003,383Vector for efficient selection and/or maturation of an antibody and uses thereof
Formerly held
Surrendered on reissue
Surrendered on reissue Apr 12, 2016 · From the USPTO record
Surrendered on reissueSurrendered on reissue Apr 12, 2016From the USPTO record
US 6,566,077Peptide useful as a ligand
Lapsed on the fee record
Ended May 20, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2015From the USPTO record
US 6,222,011Antigenic peptides
Lapsed on the fee record
Ended Apr 24, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 24, 2013From the USPTO record
US 6,207,807Method for the separation and purification of immunoglobulins
Lapsed on the fee record
Ended Mar 27, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2013From the USPTO record
US 6,426,401Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
Lapsed on the fee record
Ended Jul 30, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jul 30, 2010From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited